Pharmafile Logo

Baxter International Inc

The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Baxter International Inc in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Baxter International Inc.

Recent articles on PMLiVE featuring Baxter International Inc

Deal Watch January 2018

One key question for 2018 is whether the recent US tax changes will have an effect on M&A in our industry – time will tell.  The year opened with a small batch of >$1bn M&As although these are not particularly mega deals.  However pharma companies on t …

- PMLiVE
Chase adds former Allergan execs to leadership team

Scott Giacobello and Gary Charbonneau join

- PMLiVE
Zytoprotec expands supervisory board

Prof Joerg Vienken and Prof Norbert Riedel join the firm

Stuart Collinson joins Silence Therapeutics

He replaces Simon Sturge as non-executive director

- PMLiVE
First von Willebrand disease therapy heads new FDA approvals

Baxalta’s Vonvendi set for an early 2016 launch in the US

- PMLiVE
Astellas selects new CFO for its EMEA operations

Japanesefirm also appoints newmanager for its US corporate affairs team

- PMLiVE
Astellas forms new US corporate affairs unit

Jeff Winton will lead the department, which adds two newemployees

- PMLiVE
Baxter buoys cancer presence with $900m Oncaspar deal

Leukaemia drug will be added to upcoming biopharma firm Baxalta

- PMLiVE
FDA approves Baxter drug for rare form of haemophilia

Obizur is derived from pig proteins

Pharma deals during July 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Data provided by GlobalData

GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.

Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.

To find out more about how our research and insights can help you, please visit  https://www.globaldata.com/who-we-are/why-globaldata/

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links